| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 11/24/2011 | US20110288103 Compounds, compositions, and methods comprising 1,3,4-oxadiazole derivatives |
| 11/24/2011 | US20110288098 Novel compounds |
| 11/24/2011 | US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 11/24/2011 | US20110288093 Compounds, Compositions, and Methods Comprising Pyridazine Sulfonamide Derivatives |
| 11/24/2011 | US20110288088 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors |
| 11/24/2011 | US20110288087 Fused ring compound and use thereof |
| 11/24/2011 | US20110288083 Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase |
| 11/24/2011 | US20110288080 Nitrofuran Compounds for the Treatment of Cancer and Angiogenesis |
| 11/24/2011 | US20110288077 Compounds for the treatment of inflammatory diseases |
| 11/24/2011 | US20110288074 New adenosine receptor ligands and uses thereof |
| 11/24/2011 | US20110288073 Alpha-Aminocyclolactam Ligands for G-protein Coupled Receptors, and Methods of Using Same |
| 11/24/2011 | US20110288072 Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction |
| 11/24/2011 | US20110288068 Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 11/24/2011 | US20110288067 Pyrrolopyrazine Kinase Inhibitors |
| 11/24/2011 | US20110288064 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 11/24/2011 | US20110288060 apparatus and process for producing crystals |
| 11/24/2011 | US20110288058 Methods for Preventing or Reducing Colon Carcinogenesis |
| 11/24/2011 | US20110288051 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 11/24/2011 | US20110288044 Modulation of sodium channels by nicotinamide adenine dinucleotide |
| 11/24/2011 | US20110288037 Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System |
| 11/24/2011 | US20110288036 Methods for Treating or Preventing Vascular Graft Failure |
| 11/24/2011 | US20110288017 Apo-lipoprotein propeptide |
| 11/24/2011 | US20110288015 Treatment of renal dysfunction and multiple myeloma using pacap compounds |
| 11/24/2011 | US20110288013 Glycemic control for reduction of cardiovascular disease risk in diabetic patients expressing haptoglobin 2-2 |
| 11/24/2011 | US20110288012 Nutrition composition |
| 11/24/2011 | US20110288011 Peptide therapeutic conjugates and uses thereof |
| 11/24/2011 | US20110288009 Leptin and leptin analog conjugates and uses thereof |
| 11/24/2011 | US20110288004 Viral Sequences and Uses Thereof |
| 11/24/2011 | US20110287116 Use of jasmonates for treating heart failure and related cardiac disorders |
| 11/24/2011 | US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds |
| 11/24/2011 | US20110287103 Sustained-release formulations of topiramate |
| 11/24/2011 | US20110287100 Galenic Formulations of Organic Compounds |
| 11/24/2011 | US20110287091 Chronotherapeutic pharmaceutical composition |
| 11/24/2011 | US20110287088 Modulation of olfml-3 mediated angiogenesis |
| 11/24/2011 | US20110287080 Coating ii |
| 11/24/2011 | US20110287079 Supporting material for cell sheet |
| 11/24/2011 | US20110287078 Novel porous biomaterials |
| 11/24/2011 | US20110287066 Nanoporous Foamed Active Compound-Containing Preparations Based On Pharmaceutically Acceptable Thermoplastically Workable Polymers |
| 11/24/2011 | US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies |
| 11/24/2011 | US20110287048 Antigen Specific Tregs and related compositions, methods and systems |
| 11/24/2011 | US20110286989 ANGIOGENIN COMPLEXES (ANGex) WITH LIPID-BASED SUBSTRATES AND USES THEREOF |
| 11/24/2011 | US20110286982 Glucagon analogues |
| 11/24/2011 | US20110286981 Glucagon analogues |
| 11/24/2011 | US20110286976 Bi-specific fusion proteins |
| 11/24/2011 | US20110286972 Virus growing in hypoxic cell or virus vector expressing gene therein |
| 11/24/2011 | US20110286971 Targeted drug-carrying bacteriophages |
| 11/24/2011 | US20110286963 Human soluble cd146, preparation and uses thereof |
| 11/24/2011 | US20110286931 Cardiac arrhythmia treatment methods and biological pacemaker |
| 11/24/2011 | US20110286925 Embolizing Sclerosing Hydrogel |
| 11/24/2011 | US20110286923 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases |
| 11/24/2011 | US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 11/24/2011 | CA2836861A1 Process for producing a shrimp hydrolysate using electrodialysis |
| 11/24/2011 | CA2816928A1 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles |
| 11/24/2011 | CA2800018A1 Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders |
| 11/24/2011 | CA2799792A1 Inhibitors of human 12-lipoxygenase |
| 11/24/2011 | CA2799764A1 Mtor selective kinase inhibitors |
| 11/24/2011 | CA2798970A1 Pyrrolopyrazine derivatives as syk and jak inhibitors |
| 11/24/2011 | CA2798911A1 Theobromine for increasing hdl-cholesterol |
| 11/23/2011 | EP2388265A1 Compositions and methods for the treatment of immune related diseases |
| 11/23/2011 | EP2388263A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators |
| 11/23/2011 | EP2388248A1 Methods for the preparation of ivabradine sulfate and form i crystal thereof |
| 11/23/2011 | EP2387998A1 Methods for treating degenerative diseases/injuries |
| 11/23/2011 | EP2387997A1 Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients who developed permanent atrial fibrillation throughout the period the dronedarone is administered |
| 11/23/2011 | EP2387996A1 Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients with permanent atrial fibrillation |
| 11/23/2011 | EP2387572A2 Protein kinase c inhibitors and uses thereof |
| 11/23/2011 | EP2004576B1 New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use |
| 11/23/2011 | EP1852433B1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
| 11/23/2011 | EP1663263B1 Use of adipose tissue cells for initiating the formation of a functional vascular network |
| 11/23/2011 | EP1603553B1 Pharmaceutical compositions of cetp inhibitors |
| 11/23/2011 | EP1589964B1 Compounds having anti-proliferative properties |
| 11/23/2011 | EP1532269B1 1l1rl-1 as a cardiovascular disease marker |
| 11/23/2011 | EP1509541B1 Novel recombinant anticoagulant proteins |
| 11/23/2011 | EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 11/23/2011 | EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 11/23/2011 | EP1391451B1 2-iminopyrrolidine derivates |
| 11/23/2011 | EP1349576B1 Combined use of enzyme inhibitors for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with follicular and epidermal hyperkeratosis and reinforced keratinocyte proliferation |
| 11/23/2011 | EP1226148B1 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
| 11/23/2011 | CN202043972U Health-care pillow with headrest provided with three layers of medicine cushions |
| 11/23/2011 | CN1980673B A method for the prevention of thromboembolic disorders |
| 11/23/2011 | CN102256970A Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders |
| 11/23/2011 | CN102256617A Annexin and its use to treat inflammatory disorders |
| 11/23/2011 | CN102251037A Application of miRNA-23a antisense nucleotide in preparation of medicine for treating heart diseases |
| 11/23/2011 | CN102250914A Protein for treating ocular vascular proliferation |
| 11/23/2011 | CN102250735A Propolis wine combined with golden camellia and preparation method thereof |
| 11/23/2011 | CN102250734A Linearstripe rabdosia herb combined propolis wine and preparation method thereof |
| 11/23/2011 | CN102250733A Health-care wine matched with gynostemma pentaphylla and preparation method thereof |
| 11/23/2011 | CN102250724A Cordyceps and ginkgo yellow wine as well as preparation method and application thereof |
| 11/23/2011 | CN102250342A PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound |
| 11/23/2011 | CN102250214A Polypeptide for resisting rheumatoid arthritis and application of polypeptide in pharmacy |
| 11/23/2011 | CN102250210A Human plasminogen Kringle 5 short peptide, its pharmaceutical composition, application and polynucleotide encoding the short peptide |
| 11/23/2011 | CN102250186A Berberine-oryzanol compound, and preparation method and application thereof |
| 11/23/2011 | CN102250179A Stable protein kinase activator, and preparation method and purpose thereof |
| 11/23/2011 | CN102250171A Rutin ester compound and its application in medicaments |
| 11/23/2011 | CN102250099A Non-peptide thrombin inhibitors as well as preparation method and medical application thereof |
| 11/23/2011 | CN102250098A Pyrazinones compound |
| 11/23/2011 | CN102250097A 6-alkyloxy-2-alkylthio-8-azapurine and synthesis thereof |
| 11/23/2011 | CN102250071A Pyrazole compounds useful as protein kinase inhibitors |
| 11/23/2011 | CN102250065A Substituted triazine phenyl urea derivatives and application thereof |
| 11/23/2011 | CN102250031A High-purity valsartan compound |
| 11/23/2011 | CN102250019A (Thio) barbituric acid compound and application thereof |